2-hydroxyacetanilide has been researched along with Adjuvant Arthritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanif, F; Jamall, S; Jawed, H; Perveen, K; Simjee, SU | 1 |
Jamall, S; Jawed, H; Shah, SU; Simjee, SU | 1 |
2 other study(ies) available for 2-hydroxyacetanilide and Adjuvant Arthritis
Article | Year |
---|---|
N-(2-hydroxy phenyl) acetamide: a novel suppressor of Toll-like receptors (TLR-2 and TLR-4) in adjuvant-induced arthritic rats.
Topics: Acetanilides; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cells, Cultured; Down-Regulation; Female; Indomethacin; Inflammation Mediators; Interleukin-1beta; Joints; Mycobacterium tuberculosis; Nociception; Rats, Sprague-Dawley; RNA, Messenger; Spleen; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
N-(2-hydroxy phenyl) acetamide inhibits inflammation-related cytokines and ROS in adjuvant-induced arthritic (AIA) rats.
Topics: Acetanilides; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Biomarkers; Edema; Female; Inflammation; Interleukin-1beta; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Weight Loss | 2010 |